A 73-year-old with HFrEF has stable K+ 4.8, eGFR 45, and BP 122/72. He tolerates ARNI and beta blocker. Adding which class reduces mortality and hospi...

Question

A 73-year-old with HFrEF has stable K+ 4.8, eGFR 45, and BP 122/72. He tolerates ARNI and beta blocker. Adding which class reduces mortality and hospitalization?

Accepted Answer

MRA (e.g., spironolactone)

Answer

Non-DHP CCB

Answer

Alpha-blocker

Answer

Hydralazine alone

Answer

Ivabradine first

us-abim MCQ (SBA): HFrEF MRAs

A 73-year-old with HFrEF has stable K+ 4.8, eGFR 45, and BP 122/72. He tolerates ARNI and beta blocker. Adding which class reduces mortality and hospitalization?